Demant A/S (OTCMKTS:WILLF) PT Lowered to 306.00 at JPMorgan Chase & Co.

Demant A/S (OTCMKTS:WILLFGet Rating) had its target price decreased by research analysts at JPMorgan Chase & Co. from 308.00 to 306.00 in a note issued to investors on Tuesday, The Fly reports. The brokerage currently has a “neutral” rating on the stock.

WILLF has been the subject of a number of other reports. Stifel Nicolaus cut Demant A/S from a “buy” rating to a “hold” rating in a research report on Friday, February 25th. Kepler Capital Markets raised Demant A/S from a “reduce” rating to a “hold” rating in a research report on Friday, February 11th. Finally, Morgan Stanley reduced their price target on Demant A/S from 340.00 to 309.00 in a report on Tuesday, February 15th. One equities research analyst has rated the stock with a sell rating and five have given a hold rating to the stock. According to MarketBeat, Demant A/S has an average rating of “Hold” and a consensus price target of $307.50.

OTCMKTS:WILLF remained flat at $$38.61 during mid-day trading on Tuesday. Demant A/S has a 52 week low of $38.61 and a 52 week high of $59.30. The firm’s 50 day moving average price is $41.04 and its 200-day moving average price is $45.91.

About Demant A/S (Get Rating)

Demant A/S, a hearing healthcare and audio technology company, develops, manufactures, and sells products and equipment to enhance people's hearing in Europe, North America, the Pacific, Asia, and internationally. It operates in two segments, Hearing Healthcare and Communications. The Hearing Healthcare segment offers hearing implants and aids, hearing care, and diagnostic products.

Recommended Stories

The Fly logo

Analyst Recommendations for Demant A/S (OTCMKTS:WILLF)

Receive News & Ratings for Demant A/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Demant A/S and related companies with MarketBeat.com's FREE daily email newsletter.